Global Nerve Regeneration Market size is expected to register a CAGR of 11.34% to reach USD 12695.25 million by 2024. Nerve regeneration products are used to restore damaged nerves to their normal function, and this procedure is primarily used to treat peripheral nerve injuries. This market is witnessing high growth due to factors such as rising neurological disorders, increasing geriatric population prone to nerve-related diseases, and technological advancements.

Rising neurological disorders, increasing geriatric population susceptible to neurological diseases, and technological advancements in the field of nerve regeneration are expected to enhance the market growth. However, high cost and stringent regulatory framework are projected to restrain the market growth during the forecast period.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/1202

Key Players

The prominent players in the global nerve regeneration market are Boston Scientific Corporation, LivaNova PLC, Axogen Corporation, Integra LifeSciences, Abbott, Stryker Corporation, Nuvectra Corporation, NeuroPace, Polyganics, and Medtronic.

The players operating in the global nerve regeneration market are focusing on product launches, along with expanding their global footprints by entering untapped markets.

• In April 2019, Polyganics increased its production capacity with a new facility at the Zernike Campus, Groningen, to enter a new phase of commercial and research and development (R&D) growth.

• In June 2018, NeuroPace launched a Next-Generation RNS System, the world’s only brain-computer interface for the treatment of refractory epilepsy.

Market Dynamics

The rising neurological disorders have primarily driven the global nerve regeneration market. For instance, as per the statistics of World Health Organizations(WHO) in 2017, around 50 million people all over the world were affected by epilepsy. Various other factors, such as increasing geriatric population affected by neurological disorders and technological advancements, are also propelling the growth of the market. Moreover, the high cost of products and stringent regulatory framework are expected to hinder the market growth.

Market Segmentation

Global Nerve Regeneration Market has been segmented into Product, Application, and End User. Based on the product, the market has been segregated into neurostimulation & neuromodulation devices and biomaterials. On the basis of neurostimulation and neuromodulation devices, the market has been divided into internal neurostimulation devices and external neurostimulation devices. Neurostimulation and neuromodulation devices held a share of 4,764.96 USD million in 2018.  Internal neurostimulation devices have been further bifurcated into spinal cord stimulation, deep brain stimulation, vagus nerve stimulation, sacral nerve stimulation, and gastric electrical stimulation. External neurostimulation devices have been further segmented into transcutaneous electrical nerve stimulation, transcranial magnetic stimulation. Biomaterials have also been classified as nerve conduits, nerve protectors, nerve wraps, and nerve connectors. Based on the application, the market has been categorized as neurostimulation and neuromodulation surgeries, direct nerve repair/neurorrhaphy, nerve grafting, stem cell therapy, and others. Neurostimulation and neuromodulation surgeries have been bifurcated into internal neurostimulation and neuromodulation surgeries, external neurostimulation, and neuromodulation surgeries. Nerve grafting has been further classified as autografts, allografts, and xenografts. Based on end-user, the market has been divided into end-user, hospitals & clinics, ambulatory surgery centers, and others